Immunohistochemical Localization of Somatostatin Receptor sst2A in Human Gut and Lung Tissue: Possible Implications for Physiology and Carcinogenesis

• Published in: Annals of the New York Academy of Sciences Vol. 1014; no. 1; pp. 132 - 136
• Main Authors: Gugger, M, Waser, B, Kappeler, A, Schonbrunn, A, Reubi, JC
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-04-2004
• Subjects: carcinogenesis; gastrin cells; Gastrins - metabolism; gut; Humans; Immunohistochemistry; Intestinal Mucosa - metabolism; Intestinal Mucosa - pathology; Intestinal Neoplasms - metabolism; Intestinal Neoplasms - pathology; lung; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Neuroendocrine Tumors - metabolism; Neuroendocrine Tumors - pathology; Receptors, Somatostatin - metabolism; Respiratory Mucosa - metabolism; Respiratory Mucosa - pathology; somatostatin receptor sst2A
• ISSN: 0077-8923; 1749-6632
• DOI: 10.1196/annals.1294.013

: Many neuroendocrine gastrointestinal and lung tumors express sst2A somatostatin receptors. Because the cellular location of sst2A in the corresponding non‐neoplastic tissue is unknown, we searched for sst2A immuno‐reactive cells and characterized their type in these tissues using a highly specific sst2A antibody (R2–88). Epithelial sst2A cells, identified as neuroendocrine, gastrin‐producing cells, were found in large numbers in the antrum and the duodenum, but not in the gastric corpus. They were also present in the proximal jejunum, rarely noted in the distal jejunum and ileum, and absent in the large intestine and the appendix vermiformis. Moreover, sst2A cells were found abundantly in the neural plexus. sst2A receptors on antral gastrin cells could mediate somatostatin inhibition on gastrin secretion, whereas those in the neural plexus could mediate somatostatin effects on motility and ion transport in the lower gastrointestinal tract. Rare sst2A cells in bronchi and bronchioles located basally and parabasally in the gastrointestinal epithelium were detected that could represent stem/progenitor cells. It is currently not clear whether and which of the identified sst2A cells are at the origin of sst2A‐positive neuroendocrine gut or lung tumors.